India to Philippines: Imatinib Export Trade Route
India has recorded 58 verified shipments of Imatinib exported to Philippines, representing a combined trade value of $580.2K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $10.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 53% of total export value with 5 shipments worth $306.9K USD. On the buying side, SUN PHARMA PHILIPPINES INC. is the largest importer in Philippines with $188.9K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD. — together control 87% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Imatinib corridor is one of India's established pharmaceutical export routes, with 58 shipments documented worth a combined $580.2K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $10.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 23.3%, placing it at rank #15 among India's top imatinib export destinations globally.
On the import side, key buyers of Indian imatinib in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , SUN PHARMA PHILIPPINES INC and 10 others. SUN PHARMA PHILIPPINES INC. is the single largest importer with 3 shipments valued at $188.9K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#15
- Annual growth+23.3%
- Demand growth+21.6%
- Regulatory ease66/100
Top 10 Indian Imatinib Exporters to Philippines
Showing top 10 of 12 Indian suppliers exporting Imatinib to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $61.4K per shipment | 5 | $306.9K | 52.9% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $144.6K per shipment | 1 | $144.6K | 24.9% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $3.3K per shipment | 17 | $55.7K | 9.6% |
| 4 | VEXXA LIFESCIENCES PVT. LTD. Avg $1.6K per shipment | 18 | $29.3K | 5.0% |
| 5 | BETA DRUGS LIMITED Avg $5.3K per shipment | 3 | $15.9K | 2.7% |
| 6 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $2.4K per shipment | 5 | $12.2K | 2.1% |
| 7 | VEXXA LIFESCIENCES PVT LTD Avg $2.0K per shipment | 4 | $8.2K | 1.4% |
| 8 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $3.2K per shipment | 1 | $3.2K | 0.6% |
| 9 | GLOBELA PHARMA PRIVATE LIMITED Avg $3.1K per shipment | 1 | $3.1K | 0.5% |
| 10 | YARAPMIN LIFECARE Avg $758 per shipment | 1 | $758 | 0.1% |
This table shows the top 10 of 12 Indian companies exporting imatinib to Philippines, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. , BETA DRUGS LIMITED, VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT LTD, KHANDELWAL LABORATORIES PRIVATE LIMITED, GLOBELA PHARMA PRIVATE LIMITED, YARAPMIN LIFECARE. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 5 shipments worth $306.9K USD, giving it a 53% market share. The top 3 suppliers together account for 87% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Philippines Imatinib export route.
Top 10 Imatinib Importers in Philippines
Showing top 10 of 13 known buyers in Philippines receiving Imatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian imatinib in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , SUN PHARMA PHILIPPINES INC, VE PHARMA INC, Ve Pharma Inc. , among 13 total buyers. The largest importer is SUN PHARMA PHILIPPINES INC., accounting for $188.9K USD across 3 shipments — representing 33% of all imatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA PHILIPPINES INC. | 3 | $188.9K | 32.6% |
| 2 | SUN PHARMA PHILIPPINES INC. | 1 | $144.6K | 24.9% |
| 3 | SUN PHARMA PHILIPPINES INC | 2 | $118.0K | 20.3% |
| 4 | VE PHARMA INC | 19 | $58.6K | 10.1% |
| 5 | Ve Pharma Inc. | 18 | $29.3K | 5.0% |
| 6 | 2MG INCORPORATED | 3 | $15.9K | 2.7% |
| 7 | VE PHARMA INC. | 4 | $12.8K | 2.2% |
| 8 | Ve Pharma Inc. | 3 | $4.8K | 0.8% |
| 9 | MEDETHIX INC | 1 | $3.2K | 0.6% |
| 10 | AMB HK ENTERPRISES INC. | 1 | $3.1K | 0.5% |
Showing top 10 of 13 Imatinib importers in Philippines on this route.
Top 10 Imatinib Formulations Imported by Philippines
Showing top 10 of 28 product formulations shipped on the India to Philippines Imatinib route, ranked by trade value
Philippines imports a wide range of imatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — IMALEK TAB 100MG TABLETS (IMATINIB MESYL — accounts for $144.6K USD across 1 shipments. There are 28 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IMALEK TAB 100MG TABLETS (IMATINIB MESYL | 1 | $144.6K | 24.9% |
| 2 | IMALEK 100MG TABLETS (IMATINIB MESYLATETABLETS 100MG) [17740 PACK X1X10] | 1 | $115.3K | 19.9% |
| 3 | IMALEK TAB 100MG IMATINIB MESYLATE TABL | 1 | $100.7K | 17.4% |
| 4 | IMALEK 100 MG TABLETS (IMATINIB MESYLATETABLETS 100 MG) PACK : 01*10 SAP CODE :1149321 | 1 | $52.5K | 9.0% |
| 5 | Vexinib 100 (IMATINIB MESYLATE CAPSULE 1 | 16 | $25.5K | 4.4% |
| 6 | IMALEK TAB 400MG (IMATINIBE MESYLATE TAB | 1 | $21.1K | 3.6% |
| 7 | IMALEK TAB 400MG CONTAINS IMATINIB TABLETS SAP CODE : 1158787 BNO : PTF1035B MFD: 03/2024 EXP : 02/2027 PS: 10S STRIP | 1 | $17.3K | 3.0% |
| 8 | Vexinib 100 Caps (IMATINIB MESYLATE CAPSULE 100 MG) BATCH NO-IMCC25A03-A MFG DT-MAR-2025 EXP DT-FEB-2027 | 1 | $13.5K | 2.3% |
| 9 | VEXINIB 100 (IMATINIB MESYLATE CAPSULE | 4 | $12.8K | 2.2% |
| 10 | Vexinib 100 IMATINIB MESYLATE CAPSULE 100 MG BCH NO-IMCG23A07-A MANUFACTURING DT-JUL-2023 EXP DT-JUN-2025 | 4 | $8.2K | 1.4% |
Showing top 10 of 28 Imatinib formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 30 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's imatinib exports to Philippines are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD. — together account for 87% of total trade value on this route. The average shipment value of $10.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as imalek 100mg tablets (imatinib mesylatetablets 100mg) [17740 pack x1x10] and imalek tab 100mg imatinib mesylate tabl, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA PHILIPPINES INC. is the largest importer with 3 shipments worth $188.9K USD — representing 33% of all imatinib imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $580.2K
- Avg. Shipment
- $10.0K
- Suppliers
- 12
- Buyers
- 13
- Transit (Sea)
- ~31 days
- Annual Growth
- +23.3%
Other Imatinib Routes
Unlock the Full India to Philippines Imatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 58 shipments on this route.
Frequently Asked Questions — India to Philippines Imatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Imatinib to Philippines?
The leading Indian exporters of Imatinib to Philippines are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD.. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 53% of total trade value on this route.
Q What is the total value of Imatinib exports from India to Philippines?
India exports Imatinib to Philippines worth approximately $580.2K USD across 58 recorded shipments. The average value per shipment is $10.0K USD.
Q Which ports does India use to ship Imatinib to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 30 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Philippines for Imatinib?
The average transit time for Imatinib shipments from India to Philippines is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Imatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.3% with demand growth tracking at 21.6%. The route is ranked #15 among India's top Imatinib export destinations globally.
Q How many suppliers are active on the India to Philippines Imatinib route?
There are currently 12 active Indian suppliers exporting Imatinib to Philippines. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 53% of total shipment value.
Q Who are the main importers of Imatinib from India in Philippines?
The leading importers of Indian Imatinib in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , SUN PHARMA PHILIPPINES INC, VE PHARMA INC, Ve Pharma Inc. . SUN PHARMA PHILIPPINES INC. is the largest buyer with 3 shipments worth $188.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Imatinib.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 13 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 58 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
58 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists